Diagnostic Performance of %[-2]proPSA and Prostate Health Index for Prostate Cancer: Prospective, Multi-institutional Study.

about

Diagnostic Performance of %[-2]proPSA and Prostate Health Index for Prostate Cancer: Prospective, Multi-institutional Study.

Item

http://www.wikidata.org/entity/Q52679257

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Diagnostic Performance of %[-2 ...... ve, Multi-institutional Study.

@en

Diagnostic Performance of %[-2 ...... ve, Multi-institutional Study.

@nl

type

Item

label

Diagnostic Performance of %[-2 ...... ve, Multi-institutional Study.

@en

Diagnostic Performance of %[-2 ...... ve, Multi-institutional Study.

@nl

prefLabel

Diagnostic Performance of %[-2 ...... ve, Multi-institutional Study.

@en

Diagnostic Performance of %[-2 ...... ve, Multi-institutional Study.

@nl

P1476

Diagnostic Performance of %[-2 ...... ve, Multi-institutional Study.

@en

P2093

Chang Hoo Park

http://www.w3.org/2001/XMLSchema#string

Geehyun Song

http://www.w3.org/2001/XMLSchema#string

Hongzoo Park

http://www.w3.org/2001/XMLSchema#string

Hyun Chul Chung

http://www.w3.org/2001/XMLSchema#string

In Bum Suh

http://www.w3.org/2001/XMLSchema#string

Jae Hung Jung

http://www.w3.org/2001/XMLSchema#string

Jeong Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Jong Yeon Park

http://www.w3.org/2001/XMLSchema#string

Sang Wook Lee

http://www.w3.org/2001/XMLSchema#string

Sung Jin Kim

http://www.w3.org/2001/XMLSchema#string

P2860

PSA and beyond: alternative prostate cancer biomarkers

Biomarkers in prostate cancer: what's new?

Prostate cancer biomarkers: Are we hitting the mark?

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Screening and prostate-cancer mortality in a randomized European study

Prospective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4-10 ng ml-1.

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer.

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

P304

e94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3346/JKMS.2018.33.E94

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29495138

http://www.w3.org/2001/XMLSchema#string

P932

5835587

http://www.w3.org/2001/XMLSchema#string